Zai Lab (ZLAB) Share-based Compensation (2017 - 2026)
Zai Lab (ZLAB) posted Share-based Compensation of $13.5 million for Q1 2026, down 14.95% sequentially from $15.9 million in Q4 2025, and down 14.41% YoY from $15.8 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Share-based Compensation (2017 - 2026) Analysis & Trends
Zai Lab has reported Share-based Compensation for 10 years, with the latest figure at $13.5 million in Q1 2026.
- Quarterly Share-based Compensation fell 14.41% year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.3 million (down 7.52% YoY) and the FY2025 annual result came in at $65.6 million, down 7.15% from the prior year.
- Share-based Compensation fell to $13.5 million in Q1 2026 per ZLAB's latest filing, from $15.9 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $22.0 million in Q3 2023 and troughed at $12.4 million in Q1 2022.
- A 5-year average of $17.1 million and a median of $16.9 million in 2025 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation jumped 81.02% in 2022, then retreated 23.63% in 2024.
- Over 5 years, Share-based Compensation stood at $15.6 million in 2022, then surged by 31.56% to $20.5 million in 2023, then slipped by 15.79% to $17.2 million in 2024, then dropped by 7.75% to $15.9 million in 2025, then decreased by 14.95% to $13.5 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $13.5 million, $15.9 million, and $16.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 120.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 277.20 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 137.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 86.63 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn | 11.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.94 Mn |
| Mar 31, 2026 | 13.52 Mn |
| Dec 31, 2025 | 15.90 Mn |
| Sep 30, 2025 | 16.92 Mn |
| Jun 30, 2025 | 16.97 Mn |
| Mar 31, 2025 | 15.80 Mn |
| Dec 31, 2024 | 17.24 Mn |
| Sep 30, 2024 | 16.80 Mn |
| Jun 30, 2024 | 18.64 Mn |
| Mar 31, 2024 | 17.98 Mn |
| Dec 31, 2023 | 20.47 Mn |
| Sep 30, 2023 | 21.99 Mn |
| Jun 30, 2023 | 20.51 Mn |
| Mar 31, 2023 | 16.66 Mn |
| Dec 31, 2022 | 15.56 Mn |
| Sep 30, 2022 | 19.11 Mn |
| Jun 30, 2022 | 14.22 Mn |
| Mar 31, 2022 | 12.41 Mn |
| Dec 31, 2021 | 12.61 Mn |
| Sep 30, 2021 | 10.56 Mn |